NCT04310800 (LIFT 02) is a NA clinical trial of LIFT-plug technique in Anal Fistula, sponsored by Zhen Jun Wang.

Who is sponsoring NCT04310800?

NCT04310800 is sponsored by Zhen Jun Wang.

What drugs are being tested in NCT04310800?

Interventions in NCT04310800: LIFT-plug technique.

What condition does NCT04310800 study?

NCT04310800 studies Anal Fistula, LIFT-plug, Healing Rate, Anal Function.

Is NCT04310800 still recruiting?

NCT04310800 is currently status unknown. Last updated 17 March 2020.

Last reviewed 2020-03-17 · How we verify

NCT04310800: LIFT 02

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LIFT-plug vs LIFT, a RCT Trial

Status unknown NA Last updated 17 March 2020

What this trial tests

NA trial testing LIFT-plug technique in Anal Fistula in 384 participants. Status unknown.

Timeline

1 January 2018

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Zhen Jun Wang
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	384
Start date	1 January 2018
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	7 locations across China

Drugs / interventions tested

LIFT-plug technique

Conditions studied

Anal Fistula — all drugs for Anal Fistula →
LIFT-plug — all drugs for LIFT-plug →
Healing Rate — all drugs for Healing Rate →
Anal Function — all drugs for Anal Function →

Sponsor

Zhen Jun Wang

Who can join

Adults 18 to 70, any sex, with Anal Fistula or LIFT-plug. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To validate the effect of Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug procedure for Anal Fistula Repair in 7 medical centers

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anal Fistula

Currently open trials in the same condition.

NCT07477496 — Recurrence and Anal Fistula Patient Reported Outcomes Trial · recruiting
NCT07081373 — Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients. · NA · recruiting
NCT06803550 — Effect of Enhanced Recovery After Surgery for Benign Anorectal Conditions · NA · recruiting
NCT06303752 — Tissue Therapy of Transsphincteric Anal Fistula · Phase 1, PHASE2 · recruiting
NCT05641844 — A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal · NA · recruiting

Other Zhen Jun Wang trials

Trials by the same sponsor.

NCT05452980 — Sleeve Gastrectomy With Reestablishment of the Acute Angle of His (SG-REACH) in Obese Patients · NA · unknown
NCT04534504 — Sleeve Gastrectomy With Uncut Jejunal Bypass (SG-uncut JJB) Verus Sleeve Gastrectomy in Obese Patients · NA · unknown
NCT04319861 — Anal Fistula Plug, a Retrospective Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04310800 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhen Jun Wang
Last refreshed: 17 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04310800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing